Who owns the JAVADIN trademark?

The JAVADIN trademark is owned by Azurity Pharmaceuticals, Inc..

What class is the JAVADIN trademark registered in?

The JAVADIN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for JAVADIN?

The USPTO serial number for JAVADIN is 99013829.

What is the registration number for JAVADIN?

JAVADIN is registered under USPTO registration number 8425478.

Sealvo

Home Search: JAVADINJAVADIN #99013829

Back

Updated Oct 6, 2026·33 searches this week

View on USPTO TSDR Find similar marks

JAV

USPTO Trademark Record

REGISTERED

JAVADIN

SN 99013829·Reg 8425478·Filed Jan 21, 2025

Owner Azurity Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

JAVADIN (Serial No. 99013829), Registration No. 8425478, is a registered US trademark filed on Jan 21, 2025 by Azurity Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: September 01, 2032

Mark Intelligence

JAVADIN (Reg. #8425478) is a registered US trademark that has been protecting its owner, Azurity Pharmaceuticals, Inc., since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 21, 2025

SERIAL

99013829

REG#

8425478

REGISTERED

Sep 01, 2026

Filing Information

StatusREGISTERED

Filing DateJan 21, 2025

Serial Number99013829

Registration No.8425478

Registration DateSep 01, 2026

Status DateSep 01, 2026

Published for OppositionMar 04, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1869853

480Jul 18, 2025

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Dec 10, 2025

First use in commerce: Dec 10, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

REGISTERED-PRINCIPAL REGISTER

Sep 01, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 01, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 11, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 11, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

SOU EXTENSION 2 GRANTED

Aug 08, 2026

SOU EXTENSION 2 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Aug 08, 2026

STATEMENT OF USE PROCESSING COMPLETE

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 08, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 06, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Apr 16, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Apr 15, 2026

SOU EXTENSION 2 FILED

TEAS STATEMENT OF USE RECEIVED

Dec 12, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 12, 2025

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 08, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 30, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 30, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 30, 2025

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 29, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 04, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Mar 04, 2025

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 26, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Feb 10, 2025

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 10, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION ENTERED

Jan 21, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 21, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Jan 21, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by Azurity Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

XIF

XIFYRM

98248674

Azurity Pharmaceuticals, Inc.

REGISTERED

GOL

GOLYTELY

73409969

AZURITY PHARMACEUTICALS, INC.

REGISTERED

SER

SERVING OVERLOOKED PATIENTS

97388326

Azurity Pharmaceuticals, Inc.

REGISTERED

SER

SERVING OVERLOOKED PATIENTS

98212907

Azurity Pharmaceuticals, Inc.

REGISTERED

Other Marks by Douglas R. Wolf

Additional USPTO filings handled by the same attorney of record.

PAP

PAPERWIZ

98517408

REGISTERED

PER

PERFORMAX

98517503

REGISTERED

USP

US PALM

98774000

REGISTERED

REL

RELATIONSHIP REFEREES

98965294

REGISTERED

JAVADIN

Run a conflict check

Other Marks by Azurity Pharmaceuticals, Inc.

Other Marks by Douglas R. Wolf

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company